Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phenindione is a synthetic oral anticoagulant that functions as a Vitamin K antagonist. It interferes with the formation of vitamin K-dependent clotting factors (II, VII, IX, and X) in the liver by inhibiting vitamin K reductase, leading to depletion of reduced vitamin K (vitamin KH2). This action reduces the blood's ability to clot. It is prescribed for thromboembolic disorders such as deep vein thrombosis, pulmonary embolism, and to reduce the risk of stroke in patients with atrial fibrillation. While it has actions similar to warfarin, it is less commonly used today due to a higher incidence of severe adverse effects, including hypersensitivity reactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Phenindione.